Cargando...
Perampanel: A Selective AMPA Antagonist for Treating Seizures
Perampanel is a selective, noncompetitive AMPA receptor antagonist that has recently been approved for treating localization-related epilepsy. This article reviews the pharmacology, clinical development, efficacy, and safety/tolerability of perampanel.
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Epilepsy Society
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854741/ https://ncbi.nlm.nih.gov/pubmed/24348124 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5698/1535-7597-13.6.269 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|